Literature DB >> 30172865

Possible role of hepatic macrophage recruitment and activation in triptolide-induced hepatotoxicity.

Lu Wang1, Dengqiu Xu1, Liping Li1, Xin Xing1, Li Liu1, Mohammed Ismail Abdelmotalab2, Li Xiao3, Tao Pang4, Xin Huang1, Xinzhi Wang4, Tao Wang4, Zhenzhou Jiang4, Luyong Zhang5, Lixin Sun6.   

Abstract

Hepatic macrophages are central players in the pathogenesis of some liver diseases, but few studies have examined the effect of triptolide (TP) on these cells. In this study, we investigated the possible role of hepatic macrophage recruitment and activation in triptolide-induced hepatotoxicity based on a non-hepatotoxic dose of lipopolysaccharides (LPS). The results showed that continuous administration of TP for two weeks and a single challenge of low-dose lipopolysaccharides increased the number of hepatic macrophages but inhibited their phagocytic function. TP induced the liver to recruit monocyte-derived macrophages (MoMFs) in response to a single challenge of low-dose LPS, resulting in acute inflammation and increased sensitivity to the endotoxin. Concurrent administration of TP with LPS resulted in obvious hepatotoxicity, but a single dose of LPS did not induce hepatotoxicity. These results indicate that TP could change the number and function of hepatic macrophages to reduce the ability of the liver to clear mild endotoxins, thus increasing blood endotoxin levels and increasing the sensitivity of the liver to low-dose LPS. By investigating the critical function of hepatic macrophages in TP-induced hepatotoxicity, this study elucidated the mechanism underlying TP-induced hepatotoxicity.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Endotoxin; Hepatic macrophage; Hepatotoxicity; Inflammation; Triptolide

Mesh:

Substances:

Year:  2018        PMID: 30172865     DOI: 10.1016/j.toxlet.2018.08.017

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  8 in total

1.  Triptolide Induces Liver Injury by Regulating Macrophage Recruitment and Polarization via the Nrf2 Signaling Pathway.

Authors:  Li Liu; Xi Zhang; Xin Xing; Ismail Mohammed; Xiao-Ting Xu; Zhen-Zhou Jiang; Tao Wang; Xin Huang; Xin-Zhi Wang; Lu-Yong Zhang; Li-Xin Sun
Journal:  Oxid Med Cell Longev       Date:  2022-06-20       Impact factor: 7.310

2.  Comprehensive analysis of transcriptomics and metabolomics to understand triptolide-induced liver injury in mice.

Authors:  Jie Zhao; Cen Xie; Kanglong Wang; Shogo Takahashi; Kristopher W Krausz; Dasheng Lu; Qiong Wang; Yuhong Luo; Xianqiong Gong; Xiyan Mu; Qiao Wang; Suwen Su; Frank J Gonzalez
Journal:  Toxicol Lett       Date:  2020-08-21       Impact factor: 4.372

3.  A new perspective of triptolide-associated hepatotoxicity: the relevance of NF- κ B and NF- κ B-mediated cellular FLICE-inhibitory protein.

Authors:  Ziqiao Yuan; Zihang Yuan; Muhammad Hasnat; Haoran Zhang; Peishi Liang; Lixin Sun; Zhenzhou Jiang; Luyong Zhang
Journal:  Acta Pharm Sin B       Date:  2020-02-28       Impact factor: 11.413

4.  TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy.

Authors:  Dengqiu Xu; Sijia Li; Lu Wang; Jingwei Jiang; Lei Zhao; Xiaofei Huang; Zeren Sun; Chunjie Li; Lixin Sun; Xihua Li; Zhenzhou Jiang; Luyong Zhang
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-11-25       Impact factor: 12.910

Review 5.  The molecular pathogenesis of triptolide-induced hepatotoxicity.

Authors:  Yeqing Hu; Qiguo Wu; Yulin Wang; Haibo Zhang; Xueying Liu; Hua Zhou; Tao Yang
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

6.  Macrophage malfunction in Triptolide-induced indirect hepatotoxicity.

Authors:  Tingting Qin; Muhammad Hasnat; Yang Zhou; Ziqiao Yuan; Wenzhou Zhang
Journal:  Front Pharmacol       Date:  2022-09-26       Impact factor: 5.988

7.  Arctiin Antagonizes Triptolide-Induced Hepatotoxicity via Activation of Nrf2 Pathway.

Authors:  Yuyan Zhou; Li Xia; Weiqiang Yao; Jun Han; Guodong Wang
Journal:  Biomed Res Int       Date:  2020-10-16       Impact factor: 3.411

8.  A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1.

Authors:  Dengqiu Xu; Lei Zhao; Jingwei Jiang; Sijia Li; Zeren Sun; Xiaofei Huang; Chunjie Li; Tao Wang; Lixin Sun; Xihua Li; Zhenzhou Jiang; Luyong Zhang
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-08-31       Impact factor: 12.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.